Feyruz V. Rassool

Also affiliated with University of Maryland, Baltimore, U-M Rogel Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “The Epigenetic Hallmarks of Cancer”.

The Epigenetic Hallmarks of Cancer

Cancer Discovery(2024)10.1158/2159-8290.cd-24-0296

N/A

0.748DataRank · unranked

145 citations

Mark A. Dawson, Cigall Kadoch, Feyruz V. Rassool, Peter A. Jones, Stephen B. Baylin +1 more

Phase I Clinical Trial of DNA Methyltransferase Inhibitor Decitabine and PARP Inhibitor Talazoparib Combination Therapy in Relapsed/Refractory Acute Myeloid Leukemia

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3729

N/A

0.612DataRank · unranked

58 citations

Aksinija A. Kogan, Søren M. Bentzen, Mi Tian, Rena G. Lapidus, Vu H. Duong +7 more

PARP1 PARylates and stabilizes STAT5 in FLT3-ITD acute myeloid leukemia and other STAT5-activated cancers

Translational Oncology(2021)10.1016/j.tranon.2021.101283

N/A

0.406DataRank · unranked

14 citations

Rachel Abbotts, Christian Eberly, Mariusz Karbowski, Maria R. Baer, Tami J. Kingsbury +2 more

ZNFX1 Functions as a Master Regulator of Epigenetically Induced Pathogen Mimicry and Inflammasome Signaling in Cancer

Cancer Research(2025)10.1158/0008-5472.can-24-1286

N/A

0.345DataRank · unranked

9 citations

Rachel Abbotts, Kaushlendra Tripathi, Collin M. Coon, Saranya Rajendran, Elnaz Abbasi Farid +26 more

Pharmacologic Induction of BRCAness in BRCA-Proficient Cancers: Expanding PARP Inhibitor Use

Cancers(2022)10.3390/cancers14112640

N/A

0DataRank · unranked

45 citations

Anna J. Dellomo, Feyruz V. Rassool, Rachel Abbotts

Pim kinase inhibitor co-treatment decreases alternative non-homologous end-joining DNA repair and genomic instability induced by topoisomerase 2 inhibitors in cells with FLT3 internal tandem duplication

Oncotarget(2021)10.18632/oncotarget.28042

N/A

0DataRank · unranked

3 citations

Shivani Kapoor, Eric S. Tvedte, Kshama A. Doshi, Ying Zou, Prerna Singh +8 more

Activating STING1-dependent immune signaling in TP53 mutant and wild-type acute myeloid leukemia

Proceedings of the National Academy of Sciences(2022)10.1073/pnas.2123227119

N/A

0DataRank · unranked

22 citations

Michael J. Topper, Anna J. Dellomo, Lora Stojanovic, Lena J. McLaughlin, T. Michael Creed +7 more